These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38787285)

  • 1. Leucine-rich repeat-containing G protein-coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications.
    Sawaguchi H; Uehara T; Iwaya M; Asaka S; Nakajima T; Kamakura M; Nagaya T; Yoshizawa T; Ota H; Umemura T
    Pathol Int; 2024 Jul; 74(7):387-393. PubMed ID: 38787285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
    Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
    Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
    Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
    Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
    Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploring LGR5 as a prognostic marker of extrahepatic cholangiocarcinoma: insights from expression analysis and clinical correlations.
    Tamada H; Uehara T; Yoshizawa T; Iwaya M; Asaka S; Nakajima T; Kamakura M; Ota H
    Diagn Pathol; 2024 Aug; 19(1):116. PubMed ID: 39198902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma.
    Kuraishi Y; Uehara T; Kobayashi Y; Nakajima T; Watanabe T; Shimizu A; Ota H; Tanaka E
    Pathol Res Pract; 2019 Nov; 215(11):152623. PubMed ID: 31543221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer.
    Uchida H; Yamazaki K; Fukuma M; Yamada T; Hayashida T; Hasegawa H; Kitajima M; Kitagawa Y; Sakamoto M
    Cancer Sci; 2010 Jul; 101(7):1731-7. PubMed ID: 20384634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
    Wu XS; Xi HQ; Chen L
    World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.
    Sato K; Uehara T; Iwaya M; Nakajima T; Miyagawa Y; Suga T; Ota H; Tanaka E
    Ann Diagn Pathol; 2019 Jun; 40():161-165. PubMed ID: 31100646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
    Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
    BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
    Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
    Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.
    Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.
    Chen WW; Wang F; Zhang DS; Luo HY; Wang ZQ; Wang FH; Qiu MZ; Ren C; Wei XL; Wu WJ; Li YH; Xu RH
    BMC Cancer; 2014 Mar; 14():222. PubMed ID: 24666414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
    Hou MF; Chen PM; Chu PY
    BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.